Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities. (Q48069680)

8 February 2018

title

Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities. (English)

1 reference

8 February 2018

1 reference

2

1 reference

8 February 2018

Juan Carlos Pascual

7

1 reference

8 February 2018

Amanda Feilding

object named as

Amanda Feilding

6

0 references

Jordi Riba

object named as

Jordi Riba

8

0 references

author name string

Joaquim Soler

1

1 reference

8 February 2018

Alba Franquesa

3

1 reference

8 February 2018

Steven Barker

4

1 reference

8 February 2018

Pablo Friedlander

5

1 reference

8 February 2018

publication date

27 November 2015

1 reference

8 February 2018

number of pages

7

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

8 February 2018

volume

233

1 reference

8 February 2018

issue

5

1 reference

8 February 2018

page(s)

823-829

1 reference

8 February 2018

https://scigraph.springernature.com/pub.10.1007/s00213-015-4162-0

exact match

0 references

cites work

Using self-report assessment methods to explore facets of mindfulness

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Mindfulness: A Proposed Operational Definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

An Exploration of Common Elements in Dialectical Behavior Therapy, Mentalization Based Treatment and Transference Focused Psychotherapy in the Treatment of Borderline Personality Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

The benefits of being present: mindfulness and its role in psychological well-being

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Monoamine oxidase inhibition in brain and liver produced by beta-carbolines: structure-activity relationships and substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Inhibition by β-carbolines of monoamine uptake into a synaptosomal preparation: Structure-activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Assessment of addiction severity among ritual users of ayahuasca

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

On measuring mindfulness in psychosomatic and psychological research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Defining mindfulness by how poorly I think I pay attention during everyday awareness and other intractable problems for psychology's (re)invention of mindfulness: comment on Brown et al. (2011).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Decentering as a potential common mechanism across two therapies for generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

How Does Mindfulness Meditation Work? Proposing Mechanisms of Action From a Conceptual and Neural Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

A default mode of brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

“Ayahuasca,” the South American hallucinogenic drink: An ethnobotanical and chemical investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Cognitive reactivity to sad mood provocation and the prediction of depressive relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Mechanisms of mindfulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Relationship between meditative practice and self-reported mindfulness: the MINDSENS composite index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Assessing decentering: validation, psychometric properties, and clinical usefulness of the Experiences Questionnaire in a Spanish sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Impact of meditation training on the default mode network during a restful state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Psychometric properties of the Spanish version of the Philadelphia Mindfulness Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

The globalization of ayahuasca: harm reduction or benefit maximization?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Psychometric properties of the Dutch Five Facet Mindfulness Questionnaire (FFMQ) in patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4162-0

Metacognitive awareness and prevention of relapse in depression: empirical evidence.

21 January 2018

1 reference

12 December 2020

Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers

1 reference

12 December 2020

Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics

1 reference

12 December 2020

Relationship of posttreatment decentering and cognitive reactivity to relapse in major depression

1 reference

12 December 2020

Can psychedelic compounds play a part in drug dependence therapy?

1 reference

12 December 2020

Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study.

1 reference

12 December 2020

Characterization of eight biogenic indoleamines as substrates for type A and type B monoamine oxidase

1 reference

12 December 2020

Initial psychometric properties of the experiences questionnaire: validation of a self-report measure of decentering

1 reference

12 December 2020

An empirical study of the mechanisms of mindfulness in a mindfulness-based stress reduction program

1 reference

12 December 2020

10.1007/S00213-015-4162-0

Identifiers

DOI

1 reference

8 February 2018

PubMed ID

26612618

1 reference

8 February 2018